These findings indicate that uterine tumors exhibited the highest mutation frequencies among the SMYD genes within the tumors evaluated, with particular emphasis on the mutation frequency of SMYD1 in uterine carcinosarcoma. The gene discussed is SMYD1; the disease is tumor of uterus.